Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
486.43
+0.78 (0.16%)
Jul 20, 2026, 12:22 PM EDT - Market open
Vertex Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 30 analysts polled by S&P Global, Vertex Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $556.24. The average 1-year stock price forecast is 14.35% higher than the current stock price, while the lowest is $350 (-28.05%) and the highest is $641 (+31.78%).
Price Target: $556.24 (+14.35%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Vertex Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 21 | 22 | 21 | 21 | 21 | 20 |
| Buy | 4 | 5 | 5 | 6 | 6 | 4 |
| Hold | 5 | 4 | 5 | 5 | 4 | 4 |
| Sell | 1 | 1 | 0 | 0 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 32 | 33 | 32 | 33 | 33 | 30 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $585 | Buy | Maintains | $585 | +20.26% | Jul 16, 2026 |
| UBS | UBS | Buy Reiterates $545 → $585 | Buy | Reiterates | $545 → $585 | +20.26% | Jul 13, 2026 |
| Truist Financial | Truist Financial | Buy Maintains $542 → $560 | Buy | Maintains | $542 → $560 | +15.12% | Jul 13, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $600 | Buy | Maintains | $600 | +23.35% | Jul 13, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $550 | Buy | Reiterates | $550 | +13.07% | Jul 13, 2026 |
Financial Forecast
Revenue This Year
13.05B
from 12.00B
Increased by 8.71%
Revenue Next Year
14.34B
from 13.05B
Increased by 9.95%
EPS This Year
18.96
from 18.40
Increased by 3.06%
EPS Next Year
21.41
from 18.96
Increased by 12.91%
EPS and Forward PE are based on non-GAAP adjusted numbers.